Reviva Pharmaceuticals Hldg Inc
(RVPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,522 | -4,837 | -2,558 | -949 | -3,783 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 1 |
| Accounts payable and accrued liabilities | -499 | -587 | -650 | -537 | 775 |
| Other Working Capital | -702 | -661 | -804 | -1,244 | 1 |
| Other Operating Activity | -946 | -681 | -446 | -387 | -1,060 |
| Operating Cash Flow | $-10,669 | $-6,766 | $-4,457 | $-3,116 | $-4,067 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 3,110 |
| Common Stock Issued | 31,596 | 31,498 | 31,498 | N/A | 341 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 9,376 |
| Financing Cash Flow | $31,596 | $31,498 | $31,498 | $N/A | $12,827 |
| Beginning Cash Position | 8,761 | 8,761 | 8,761 | 8,761 | 0 |
| End Cash Position | 29,688 | 33,492 | 35,801 | 5,644 | 8,761 |
| Net Cash Flow | $20,928 | $24,731 | $27,041 | $-3,116 | $8,760 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,669 | -6,766 | -4,457 | -3,116 | -4,067 |
| Free Cash Flow | -10,669 | -6,766 | -4,457 | -3,116 | -4,067 |